DMS Group: First ESG Rating Revealed

On May 28, 2024, Diagnostic Medical Systems Group (DMS) published its first ESG rating, assessed by the EthiFinance agency. The group obtained a score of 70/100, placing itself 13 points above the average in its sector. This result indicates a level of “advanced maturity”.

The overall score is broken down into several themes: Environment with 61/100, Social with 91/100, Governance with 61/100, and External Stakeholders with 66/100. DMS particularly stands out in the social area with a high score of 91/100.

DMS Group pursues an ambitious ESG policy. Measures include the addition of two independent directors, 40% female representation on the Board of Directors, and the creation of an Audit Committee for regulatory CSR matters. A CSR strategy is also being developed.

The company now aims to achieve a level of “exemplary maturity” through these initiatives. According to Samuel Sancerni, CEO of DMS Group, this recognition validates the efforts made and encourages the company to maintain the trajectory.